Kensington Capital Ventures

Kensington Capital Holdings, LLC is a single-family office established to manage the financial interests of its founding family. The firm engages in a diverse range of investment activities, including allocations to private equity funds, managed public equity, and hedge funds, alongside direct investments into operating companies. Kensington Capital Holdings prioritizes long-term value creation, portfolio diversification, and capital preservation, strategically deploying resources across various sectors and geographies. The firm primarily targets investments within the consumer, technology, and healthcare industries.

Founded in 2008, Kensington Capital Holdings represents the financial interests of the family of Bob Gay, who previously served as a Managing Director of Bain Capital and is a Co-Founder and Executive Director of HGGC, a private equity firm. The firm's direct investment strategy spans early to later stage growth deals, with a historical emphasis on Series A funding rounds, often including capital reserved for subsequent follow-on investments.

Kensington Capital Holdings has a notable investment track record, having made 72 investments and achieved 41 exits. Their portfolio includes companies such as Reform RX in the recreational goods industry, Clene in drug discovery, and MelliCell. Other past investments feature Vengo Labs, NatureBox, Spare, and Tava Indian Kitchen.

The firm operates with a lean team of four members, including two partners. Kensington Capital Holdings focuses on identifying and building long-term relationships with leading fund managers, while also actively seeking out emerging and proven fund managers in global economies, with current positions held with managers investing in the USA, Europe, Asia, and South America.